At Axela Biosciences, our team combines deep scientific expertise with decades of industry experience to accelerate innovation in drug discovery, bioanalysis, genomics, and proteomics. Our scientists are trained at world-renowned institutions such as MIT, NIH, MSKCC, Mount Sinai, Rutgers, and NYU, and bring leadership experience from top biopharma companies including Novartis, Sanofi, Merck, BMS/Celgene, and Boehringer Ingelheim.

We specialize in designing and executing cellular and molecular assays to evaluate drug efficacy, investigate mechanisms of action, and monitor gene and protein expression in samples from cell cultures, animal models, and patients. Our scientific rigor and commitment to innovation are matched by our collaborative approach.

We believe that strong partnerships drive scientific breakthroughs. That’s why our strategy focuses on building trusted R&D collaborations with biotech, pharmaceutical, diagnostic, government, and academic partners. Together, we deliver tailored solutions that support the development of life-saving therapies and advance precision medicine.